An implementation trial to mAnage siCkle CELl disEase through incReased AdopTion of hydroxyurEa in Nigeria (ACCELERATE): Study protocol.
<h4>Background</h4>Despite the proven efficacy of evidence-based healthcare interventions in reducing adverse outcomes and mortality associated with Sickle Cell Disease (SCD), a vast majority of affected individuals in Africa remain deprived of such care. Hydroxyurea (HU) utilization amo...
Saved in:
Main Authors: | Emmanuel Peprah, Joyce Gyamfi, John Patena, Hazal Kayalioglu, Tania Hameed, Gbenga Ogedegbe, Hyungrok Do, Dike Ojji, Deborah Adenikinju, Tayo Ajaye Oba, Maxwell Nwegbu, Hezekiah Isa, Grace Shedul, Alayo Y Sopekan, Obiageli E Nnodu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2025-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0311900 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An implementation trial to mAnage siCkle CELl disEase through incReased AdopTion of hydroxyurEa in Nigeria (ACCELERATE): Study protocol
by: Emmanuel Peprah, et al.
Published: (2025-01-01) -
Awareness, attitude, and acceptance of newborn screening for sickle cell disease among health workers and caregivers at primary healthcare centers in Gwagwalada Area Council, Federal Capital Territory, Abuja, Nigeria
by: Isa Hezekiah A, et al.
Published: (2025-01-01) -
Hydroxyurea Treatment for Sickle Cell Disease
by: Martin H. Steinberg
Published: (2002-01-01) -
Uroprotective and Hepatoprotective Potential of Anagallis arvensis against the Experimental Animal Model
by: Ushna Shabbir, et al.
Published: (2022-01-01) -
The modern use of hydroxyurea for children with sickle cell anemia
by: Charles T. Quinn, et al.
Published: (2025-01-01)